CLINICAL ROLE -
Updates on 2022 Changes to the American Diabetes Association Standards of Care
Metformin has been the drug of choice for the treatment of diabetes since the 1950s, but new changes suggest the consideration of SGLT-2 inhibitors or GLT-1 agonists.
Read More